Jeffrey Cheng-Ta Peng, MD
Sports Medicine · Campbell
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Office
- 1
Offices
1 location · University Healthcare Alliance · 334 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Peng’s office at (408) 357-1410 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A144595 · Current
Licensed to practise in California · since 2016 · expires 2028-07-31 · Medical College of Wisconsin.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$108,065
Medicare paid this office $108,065 for 231 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 148 | $24,433 | $83 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 74 | $16,070 | $114 |
| New patient visit (45+ min) | 101 | $14,368 | $142 |
| Return visit (30+ min) | 86 | $13,632 | $111 |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 25 | $11,938 | None |
See all 11 services
| Short return visit (20+ min) | 148 | $24,433 | $83 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 74 | $16,070 | $114 |
| New patient visit (45+ min) | 101 | $14,368 | $142 |
| Return visit (30+ min) | 86 | $13,632 | $111 |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 25 | $11,938 | None |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 109 | $9,429 | $59 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 14 | $4,188 | None |
| New patient visit (30+ min) | 20 | $1,512 | $76 |
| Injection of trigger points, 1-2 muscles | 11 | $1,050 | $50 |
| Injection, methylprednisolone acetate, 1 mg | 44 | $260 | None |
| Injection, methylprednisolone acetate, 40 mg | 17 | $106 | None |
Who their Medicare patients are
231 Original Medicare patients in 2024. Average age 73 · Women 53% · Also on Medicaid 7% · Health risk score 0.80. At or below the middle of the specialty; the typical sports medicine clinician is at 1.05.
Conditions among them: High blood pressure 58% · Coronary heart disease 20% · Diabetes 15% · Cancer 14% · Chronic kidney disease 13% · Depression 12% · Atrial fibrillation 10% · Heart failure 8% · COPD 6%.
The office billed $485,143, Medicare allowed $145,008 and paid $108,065; for 5,812 services of 26 kinds; $23,052 of it was for drugs given in the office and $85,013 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 231 | 5,812 | 73 | 0.80 | $485,143 | $108,065 |
| 2023 | 185 | 1,050 | 74 | 0.87 | $353,806 | $81,164 |
| 2022 | 208 | 1,083 | 74 | 1.28 | $351,517 | $86,154 |
| 2021 | 224 | 868 | 74 | 1.77 | $318,920 | $83,511 |
| 2020 | 198 | 822 | 74 | 1.88 | $258,645 | $58,756 |
| 2019 | 96 | 182 | 75 | 1.70 | $75,885 | $17,072 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 69 | $18,756 | $110 |
| Short return visit (20+ min) | 87 | $14,547 | $85 |
| New patient visit (45+ min) | 95 | $13,837 | $146 |
| Return visit (30+ min) | 68 | $11,476 | $116 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 23 | $6,635 | None |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 89 | $4,549 | $39 |
| Long return visit (40+ min) | 16 | $2,777 | $163 |
| New patient visit (30+ min) | 19 | $1,637 | $86 |
| Injection of trigger points, 3 or more muscles | 15 | $1,492 | $57 |
| Injection of trigger points, 1-2 muscles | 21 | $1,238 | $44 |
| Ultrasonic guidance for needle placement | 14 | $897 | $43 |
| Injection, methylprednisolone acetate, 40 mg | 60 | $747 | None |
2022: 15 services
| Return visit (30+ min) | 116 | $22,963 | $102 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 49 | $13,456 | $117 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $7,857 | $95 |
| Short return visit (20+ min) | 56 | $7,033 | $81 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 20 | $6,669 | None |
| New patient visit (45+ min) | 34 | $4,699 | $138 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,559 | $182 |
| Long return visit (40+ min) | 21 | $3,932 | $157 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 55 | $3,449 | $57 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $2,063 | $159 |
| Injection of trigger points, 1-2 muscles | 13 | $1,284 | $49 |
| Hospital discharge day management, 30 minutes or less | 17 | $1,210 | $71 |
| Administration of influenza virus vaccine | 12 | $448 | $37 |
| Injection, methylprednisolone acetate, 40 mg | 24 | $152 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 22 | $110 | None |
2021: 13 services
| Return visit (30+ min) | 96 | $23,249 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 62 | $14,773 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $8,589 | $179 |
| Long return visit (40+ min) | 36 | $7,035 | $144 |
| Short return visit (20+ min) | 31 | $4,593 | $85 |
| Hospital discharge day management, 30 minutes or less | 51 | $3,324 | $65 |
| New patient visit (45+ min) | 22 | $3,179 | $144 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 16 | $3,098 | $100 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $2,418 | $161 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 36 | $2,173 | $54 |
| Influenza vaccine split virus, preservative free | 16 | $1,044 | $65 |
| Administration of influenza virus vaccine | 17 | $388 | $22 |
| Injection, methylprednisolone acetate, 40 mg | 18 | $142 | None |
2020: 13 services
| Return visit (30+ min) | 86 | $17,176 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $8,701 | $185 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $8,674 | $99 |
| Short return visit (20+ min) | 42 | $3,302 | $60 |
| Hospital discharge day management, 30 minutes or less | 39 | $2,842 | $69 |
| New patient visit (45+ min) | 17 | $2,011 | $118 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 15 | $1,700 | $94 |
| New patient visit (30+ min) | 16 | $1,439 | $90 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 15 | $1,254 | $52 |
| Influenza vaccine split virus, preservative free | 20 | $1,189 | $59 |
| Administration of influenza virus vaccine | 20 | $417 | $21 |
| Administration of pneumococcal vaccine | 15 | $312 | $21 |
| Injection, methylprednisolone acetate, 80 mg | 12 | $140 | None |
2019: 5 services
| Return visit (30+ min) | 35 | $3,937 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,798 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,696 | $93 |
| Short return visit (20+ min) | 14 | $1,271 | $71 |
| Hospital discharge day management, 30 minutes or less | 12 | $799 | $67 |
Medicaid work
$39,476 in 2024
Medicaid paid $39,476 for 330 billed services this clinician did in 2024, up to 36 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 152 | $38,129 |
| Short return visit (20+ min) | 178 | $1,347 |
| 2024 | 330 | 2 | 36 | $39,476 |
| 2023 | 605 | 3 | 38 | $67,013 |
| 2022 | 406 | 5 | 43 | $30,094 |
| 2021 | 839 | 6 | 59 | $82,702 |
| 2020 | 290 | 2 | 47 | $40,789 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 273 | $66,016 |
| Short return visit (20+ min) | 308 | $997 |
| Return visit (30+ min) | 24 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 118 | $27,670 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 136 | $1,695 |
| 1ST HOSP IP/OBS HIGH 75 | 19 | $320 |
| Short return visit (20+ min) | 117 | $221 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 16 | $188 |
2021
| Clinic visit/encounter, all-inclusive | 342 | $80,479 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 70 | $641 |
| Short return visit (20+ min) | 320 | $588 |
| 1ST HOSP IP/OBS HIGH 75 | 25 | $524 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 27 | $338 |
| Short return visit | 55 | $131 |
2020
| Clinic visit/encounter, all-inclusive | 178 | $40,464 |
| Short return visit (20+ min) | 112 | $325 |
Drugs they prescribed that Part D paid
$991
Pharmacies billed $991 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
111 generic and 11 brand-name prescriptions · $991 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Amlodipine Besylate | 11 | $43 | $4 |
| Meloxicam | 16 | $34 | $2 |
Year by year
| 2024 | 122 | 46 | None | 9% | $991 |
| 2023 | 493 | 86 | None | None | $21,014 |
| 2022 | 1,267 | 123 | None | 9% | $64,432 |
| 2021 | 1,367 | 151 | 1% (16) | None | $67,374 |
| 2020 | 922 | 119 | 2% (16) | None | $44,723 |
| 2019 | 114 | 58 | None | 16% | $4,208 |
| 2018 | 538 | 67 | 2% (11) | None | $30,760 |
| 2017 | 465 | 65 | 5% (22) | None | $27,260 |
| 2016 | 36 | 12 | 0% (0) | None | $4,620 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Amlodipine Besylate | 30 | $960 | $32 |
| Atorvastatin | 62 | $935 | $15 |
| Losartan | 34 | $718 | $21 |
| Rosuvastatin | 27 | $586 | $22 |
| Levothyroxine | 21 | $416 | $20 |
| Metformin | 22 | $317 | $14 |
| Triamcinolone Acetonide | 15 | $303 | $20 |
| Clopidogrel | 16 | $264 | $17 |
| Metformin Hcl Er | 13 | $246 | $19 |
| Gabapentin | 11 | $243 | $22 |
| Fluticasone Propionate | 11 | $243 | $22 |
| Lisinopril | 12 | $217 | $18 |
| Mirtazapine | 11 | $145 | $13 |
| Meloxicam | 24 | $54 | $2 |
2022: 33 drugs
| Eliquis | 17 | $16,716 | $983 |
| Rosuvastatin | 56 | $2,475 | $44 |
| Atorvastatin | 152 | $1,667 | $11 |
| Levothyroxine | 56 | $1,094 | $20 |
| Losartan | 78 | $1,067 | $14 |
| Gabapentin | 17 | $679 | $40 |
| Amlodipine Besylate | 71 | $640 | $9 |
| Metoprolol | 28 | $637 | $23 |
| Albuterol Sulfate Hfa | 11 | $622 | $57 |
| Triamcinolone Acetonide | 28 | $613 | $22 |
| Omeprazole | 22 | $595 | $27 |
| Tamsulosin | 40 | $577 | $14 |
| Alendronate | 35 | $529 | $15 |
| Clopidogrel | 16 | $341 | $21 |
| Metformin | 38 | $324 | $9 |
| Fluticasone Propionate | 19 | $319 | $17 |
| Famotidine | 11 | $314 | $29 |
| Escitalopram | 15 | $287 | $19 |
| Montelukast | 13 | $225 | $17 |
| Diclofenac | 13 | $224 | $17 |
| Lisinopril | 27 | $213 | $8 |
| Metformin Hcl Er | 28 | $204 | $7 |
| Lorazepam | 19 | $200 | $11 |
| Simvastatin | 14 | $167 | $12 |
| Carvedilol | 11 | $161 | $15 |
| Allopurinol | 11 | $148 | $13 |
| Zolpidem | 19 | $133 | $7 |
| Metoprolol | 16 | $132 | $8 |
| Mirtazapine | 11 | $121 | $11 |
| Spironolactone | 20 | $110 | $5 |
| Furosemide | 20 | $72 | $4 |
| Atenolol | 14 | $50 | $4 |
| Celecoxib | 14 | $0 | $0 |
2021: 34 drugs
| Eliquis | 17 | $13,269 | $781 |
| Rosuvastatin | 62 | $2,921 | $47 |
| Atorvastatin | 159 | $2,042 | $13 |
| Losartan | 74 | $1,176 | $16 |
| Metoprolol | 42 | $1,119 | $27 |
| Levothyroxine | 44 | $978 | $22 |
| Tamsulosin | 49 | $974 | $20 |
| Triamcinolone Acetonide | 28 | $677 | $24 |
| Amlodipine Besylate | 76 | $665 | $9 |
| Gabapentin | 20 | $638 | $32 |
| Fenofibrate | 12 | $567 | $47 |
| Potassium Chloride | 14 | $547 | $39 |
| Omeprazole | 33 | $496 | $15 |
| Diclofenac | 22 | $470 | $21 |
| Fluticasone Propionate | 32 | $470 | $15 |
| Alendronate | 33 | $367 | $11 |
| Valproic Acid | 12 | $346 | $29 |
| Lisinopril | 41 | $321 | $8 |
| Metformin | 36 | $272 | $8 |
| Oxycodone | 11 | $236 | $21 |
| Escitalopram | 13 | $231 | $18 |
| Clopidogrel | 16 | $191 | $12 |
| Metoprolol | 25 | $188 | $8 |
| Zolpidem | 23 | $173 | $8 |
| Metformin Hcl Er | 27 | $166 | $6 |
| Montelukast | 11 | $160 | $15 |
| Lorazepam | 18 | $142 | $8 |
| Furosemide | 23 | $140 | $6 |
| Mirtazapine | 13 | $126 | $10 |
| Simvastatin | 13 | $125 | $10 |
| Carvedilol | 11 | $106 | $10 |
| Atenolol | 12 | $44 | $4 |
| Hydrochlorothiazide | 11 | $24 | $2 |
| Celecoxib | 12 | $11 | $1 |
2020: 24 drugs
| Eliquis | 15 | $12,267 | $818 |
| Amitiza | 16 | $3,079 | $192 |
| Rosuvastatin | 42 | $1,419 | $34 |
| Atorvastatin | 84 | $1,063 | $13 |
| Levothyroxine | 32 | $864 | $27 |
| Fluticasone Propionate | 42 | $563 | $13 |
| Amlodipine Besylate | 75 | $550 | $7 |
| Losartan | 33 | $525 | $16 |
| Gabapentin | 18 | $417 | $23 |
| Metoprolol | 19 | $415 | $22 |
| Tamsulosin | 19 | $316 | $17 |
| Metformin | 24 | $294 | $12 |
| Fenofibrate | 11 | $261 | $24 |
| Lisinopril | 30 | $227 | $8 |
| Alendronate | 31 | $225 | $7 |
| Omeprazole | 16 | $205 | $13 |
| Triamcinolone Acetonide | 13 | $140 | $11 |
| Metformin Hcl Er | 24 | $130 | $5 |
| Zolpidem | 14 | $119 | $8 |
| Lorazepam | 16 | $113 | $7 |
| Verapamil Er | 12 | $108 | $9 |
| Furosemide | 11 | $103 | $9 |
| Famotidine | 13 | $65 | $5 |
| Metoprolol | 15 | $46 | $3 |
2018: 14 drugs
| Spiriva Respimat | 11 | $4,032 | $367 |
| Ventolin Hfa | 11 | $621 | $56 |
| Atorvastatin | 48 | $436 | $9 |
| Levothyroxine | 18 | $403 | $22 |
| Hydrocodone-Acetaminophen | 11 | $352 | $32 |
| Metformin | 32 | $193 | $6 |
| Metoprolol | 23 | $171 | $7 |
| Amlodipine Besylate | 47 | $168 | $4 |
| Lisinopril | 29 | $145 | $5 |
| Buspirone | 12 | $136 | $11 |
| Fluticasone Propionate | 13 | $128 | $10 |
| Losartan | 21 | $120 | $6 |
| Ibuprofen | 12 | $63 | $5 |
| Simvastatin | 11 | $39 | $4 |
2017: 11 drugs
| Eliquis | 13 | $4,706 | $362 |
| Voltaren | 11 | $557 | $51 |
| Hydrocodone-Acetaminophen | 13 | $514 | $40 |
| Atorvastatin | 34 | $478 | $14 |
| Gabapentin | 20 | $362 | $18 |
| Buspirone | 17 | $195 | $11 |
| Metformin | 29 | $158 | $5 |
| Lisinopril | 22 | $143 | $6 |
| Amlodipine Besylate | 36 | $134 | $4 |
| Omeprazole | 13 | $77 | $6 |
| Paroxetine | 11 | $63 | $6 |
Money from drug and device companies
$924 in 2019
A payment is not proof that care is biased.
| Evolution Surgical | None | $924 | 1 payment
|
See the published payment
| Evolution Surgical | Education · 2019-05-22 | None | $924 |
Professional record
- NPI
- 1538541255
- Licence
- CA A144595California A144595: Current · expires 2028-07-31
- Trained
- Medical College of Wisconsin, 2015
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207QS0010X (207QS0010X); Family medicine (207Q00000X)
- Mailing address
- 50 E Hamilton Ave Ste 120, Campbell, CA, 95008
- NPI first listed
- 2015-06-19
- NPI last updated
- 2023-01-18
- NPI record certified
- 2023-01-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 455 Oconnor Dr, San Jose, CA, 95128